#$%^&*AU2020203126A120200604.pdf#####Abstract The present invention is directed to pharmaceutical solution comprising at least dopamine for use in treating Parkinson's disease, wherein said pharmaceutical solution is kept under 5 anaerobic conditions from its formulation to its administration.